Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$1.35 - $3.36 $18,697 - $46,536
-13,850 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.42 - $4.48 $33,517 - $62,048
13,850 New
13,850 $55,000
Q2 2020

Aug 14, 2020

SELL
$1.56 - $3.65 $20,261 - $47,406
-12,988 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.19 - $7.56 $41,431 - $98,189
12,988 New
12,988 $96,000

About Eloxx Pharmaceuticals, Inc.


  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.